Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06736548 · ClinicalTrials.gov registry record · NA
Sleep Treatment Education Program for Cancer Survivors: STEP-Together
A NA study of Insomnia and Survivorship, sponsored by Dana-Farber Cancer Institute.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT06736548: Recruiting NA study of Insomnia and Survivorship, sponsored by Dana-Farber Cancer Institute.
NCT06736548 is a NA study of Insomnia and Survivorship that is actively recruiting participants, run by Dana-Farber Cancer Institute. The registered enrollment target is 100 participants, below the 170-participant average among 151 other Insomnia trials with a reported enrollment target (41% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06736548, a NA study of Insomnia and Survivorship, is actively recruiting participants, sponsored by Dana-Farber Cancer Institute.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
This single-arm research study of off-treatment cancer survivors with self-reported symptoms of insomnia will test the Sleep Treatment Education Program Together (STEP-Together) intervention which is delivered as a synchronous group session by videoconference.
Conditions Studied
Interventions
- BEHAVIORAL The Sleep Treatment Education Program Together (STEP-Together)
- BEHAVIORAL Coaching Session
Study Locations (1)
Massachusetts
- Dana Farber Cancer Institute - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2025-06-25 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
What NCT06736548 shows while recruiting
NCT06736548 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 170-participant average among 151 other Insomnia trials with a reported enrollment target (41% lower).
The record links to 3 conditions, with Insomnia appearing as the primary indexed condition, and to 2 interventions - of which The Sleep Treatment Education Program Together (STEP-Together) is the first listed.
NCT06736548 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06736548 about?
NCT06736548 is a clinical study titled "Sleep Treatment Education Program for Cancer Survivors: STEP-Together". This single-arm research study of off-treatment cancer survivors with self-reported symptoms of insomnia will test the Sleep Treatment Education Program Together (STEP-Together) intervention which is delivered as a synchronous group session by videoconference.
What is the current status of trial NCT06736548?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2025-06-25. Estimated completion is 2026-12-31.
What conditions does trial NCT06736548 study?
This clinical trial studies the following conditions: Insomnia, Survivorship, Insomnia Chronic.
What interventions are being tested in trial NCT06736548?
The interventions under investigation include: The Sleep Treatment Education Program Together (STEP-Together) (BEHAVIORAL), Coaching Session (BEHAVIORAL).
Who is sponsoring clinical trial NCT06736548?
This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06736548 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Insomnia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06736548's enrollment target sits among peer trials
100 61st of 151 higher than 85 of 151 other Insomnia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Insomnia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Treatments for Insomnia in Veterans With PTSD
RECRUITING · NA
-
Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
RECRUITING · NA
-
mPATH for Low-income Older Adults
RECRUITING · NA
-
Accelerated Treatment for Co-occurring Insomnia, Nightmares, and PTSD
RECRUITING · NA
-
Adapted CBT-I for Adolescents With Insomnia : The DREAM-IT Study
RECRUITING · NA
-
Treatments in Women Veterans With Insomnia and PTSD
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI